Analyte Meter Including an RFID Reader

• US 20160235300A1
• Filed: 04/22/2016
• Published: 08/18/2016
• Est. Priority Date: 02/08/2005
• Status: Active Grant

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Goodnow, Timothy T., He, Lei (Lawrence)
• Granted Patent: US 9,907,470 B2
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 2562/0295 Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157 disposable multilayered or laminated electrodes G01N27/307; details of handling chemical test elements G01N33/4875
• CPC Class Codes: A61B 2562/08 Sensors provided with means for identification, e.g. barcodes or memory chips
• CPC Class Codes: A61B 2562/085 combined with means for recording calibration data
• CPC Class Codes: A61B 5/0004 characterised by the type of physiological signal transmitted
• CPC Class Codes: A61B 5/0022 Monitoring a patient using a global network, e.g. telephone networks, internet
• CPC Class Codes: A61B 5/0026 characterised by the transmission medium
• CPC Class Codes: A61B 5/14503 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1473 invasive, e.g. introduced into the body by a catheter A61B5/1482 takes precedence
• CPC Class Codes: A61B 5/14735 comprising an immobilised reagent
• CPC Class Codes: A61B 5/1486 using enzyme electrodes, e.g. with immobilised oxidase
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61B 5/150358 Strips for collecting blood, e.g. absorbent optical reagent test strips G01N21/8483; chemical reagent test strips G01N33/4875, G01N33/52
• CPC Class Codes: A61B 5/7275 Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
• CPC Class Codes: A61B 5/7282 Event detection, e.g. detecting unique waveforms indicative of a medical condition A61B5/4094, A61B5/4818, A61B5/349, A61B5/0823 take precedence
• CPC Class Codes: A61B 5/742 using visual displays A61B5/339 takes precedence
• CPC Class Codes: A61B 90/90 Identification means for patients or instruments, e.g. tags
• CPC Class Codes: A61B 90/98 using electromagnetic means, e.g. transponders
• CPC Class Codes: G01N 33/48771 Coding of information, e.g. calibration data, lot number
• CPC Class Codes: G06K 7/10366 the interrogation device being adapted for miscellaneous applications
• CPC Class Codes: G08C 17/02 : using a radio link

Abstract

A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.

Claims

1-58. -58. (canceled)

59. An analyte monitoring system for use in diabetes management, comprising:

a radio frequency identification (RFID) reader that transmits a first radio wave and receives a second radio wave; and

an analyte sensing device, comprising;

a partially or fully implantable in vivo analyte sensor; and

an RFID sensor comprising a memory in which digitally encoded diabetes information of the partially or fully implantable in vivo analyte sensor is stored therein,

wherein the RFID sensor receives the first radio wave from the RFID reader and, after receipt of the first radio wave, transmits the diabetes information in the second radio wave to the RFID reader, and

wherein the RFID reader reads the diabetes information in the second radio wave received from the RFID sensor.

60. The analyte monitoring system of claim 59, wherein the RFID sensor is a passive RFID sensor.

61. The analyte monitoring system of claim 60, wherein the first radio wave is an interrogation signal and the second radio wave is a backscattered radio wave, and wherein the RFID sensor transmits the second radio wave in response to impingement of the first radio wave on an antenna of the RFID sensor.

62. The analyte monitoring system of claim 60, wherein the RFID sensor uses power from the first radio wave.

63. The analyte monitoring system of claim 60, wherein the passive RFID sensor does not comprise a battery.

64. The analyte monitoring system of claim 59, wherein the RFID sensor is an active RFID sensor.

65. The analyte monitoring system of claim 59, wherein the RFID sensor is part of an RFID tag.

66. The analyte monitoring system of claim 59, wherein the RFID sensor is a chip mounted on a PCB substrate.

67. The analyte monitoring system of claim 59, wherein the RFID sensor comprises a transponder that receives the first radio wave and transmits the second radio wave, containing the diabetes information, after receipt of the first radio wave.

68. The analyte monitoring system of claim 59, wherein the diabetes information is calibration information, expiration information, data representing a lot number, data representing a manufacture date, or data representing a sensor type.

69. The analyte monitoring system of claim 59, wherein the analyte sensing device comprises an antenna.

70. The analyte monitoring system of claim 69, wherein the antenna is a loop antenna.

71. The analyte monitoring system of claim 69, wherein the antenna is a dipole antenna.

72. The analyte monitoring system of claim 69, wherein the antenna is integrated with the in vivo analyte sensor.

73. The analyte monitoring system of claim 72, wherein the in vivo analyte sensor comprises a substrate, and wherein the antenna comprises a conducting loop extending around substantially a perimeter of the substrate and has two ends coupled with the RFID sensor.

74. The analyte monitoring system of claim 59, wherein the in vivo analyte sensor comprises a plurality of electrodes that include a working electrode and a counter electrode.

75. The analyte monitoring system of claim 74, wherein the plurality of electrodes includes a reference electrode.

76. The analyte monitoring system of claim 74, wherein the in vivo analyte sensor comprises an analyte monitoring circuit having the plurality of electrodes and a bodily fluid application portion.

77. The analyte monitoring system of claim 59, wherein the analyte sensing device performs electrolysis on a bodily fluid.

78. The analyte monitoring system of claim 59, wherein the RFID reader comprises a pump.

79. The analyte monitoring system of claim 59, wherein the RFID reader comprises a housing with a display and one or more operational buttons.

80. The analyte monitoring system of claim 59, wherein the RFID reader comprises a transceiver and an antenna.

81. The analyte monitoring system of claim 80, wherein the RFID reader further comprises a directional coupler that couples the transceiver to the antenna.

82. The analyte monitoring system of claim 80, wherein the transceiver and antenna of the RFID reader supply power to the RFID sensor with the first radio wave.

83. The analyte monitoring system of claim 59, wherein the RFID reader has processing capability and reads the diabetes information from the second radio wave and uses the diabetes information to determine an analyte level of a bodily fluid.

84. The analyte monitoring system of claim 59, wherein the RFID reader transmits a third radio wave to the RFID sensor, the third radio wave including information to be written to the RFID sensor.

85. The analyte monitoring system of claim 59, wherein the RFID reader is capable of programming the RFID sensor.

86. The analyte monitoring system of claim 59, wherein the RFID reader further comprises an analyte meter and a test strip port.

87. The analyte monitoring system of claim 86, further comprising circuitry for determining the analyte level of a bodily fluid sample on a test strip inserted into the port.

88. The analyte monitoring system of claim 59, wherein the RFID reader is integrated with an analyte meter.

89. The analyte monitoring system of claim 59, further comprising a modular analyte meter.

90. The analyte monitoring system of claim 59, wherein the RFID reader communicates data with an analyte meter by way of a cable, multi-pin connection, or wireless connection.

91. The analyte monitoring system of claim 59, wherein the RFID reader shares processing capability with an analyte meter.

92. The analyte monitoring system of claim 59, wherein the RFID reader shares memory with an analyte meter.

93. The analyte monitoring system of claim 59, wherein the RFID reader is a component of another device.

94. The analyte monitoring system of claim 59, wherein the analyte is glucose.

95. The analyte monitoring system of claim 59, wherein the first radio wave is in a frequency band around 13.56 MHz.

96. The analyte monitoring system of claim 59, wherein the first radio wave is in a frequency band around 2.45 GHz.